<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Ephedrine Powder to Tablets: No Credit Reversal Needed, But Removal Incurs Central Excise Duty.</title>
    <link>https://www.taxtmi.com/highlights?id=43163</link>
    <description>When the inputs are Ephedrine Powder, then the removal in the form of tablets will not be removal as such requiring reversal of credit. If they are removed as Ephedrine tablets after manufacture then these attract Central Excise duty.</description>
    <language>en-us</language>
    <pubDate>Sat, 08 Dec 2018 07:46:30 +0530</pubDate>
    <lastBuildDate>Sat, 08 Dec 2018 07:46:30 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=546145" rel="self" type="application/rss+xml"/>
    <item>
      <title>Ephedrine Powder to Tablets: No Credit Reversal Needed, But Removal Incurs Central Excise Duty.</title>
      <link>https://www.taxtmi.com/highlights?id=43163</link>
      <description>When the inputs are Ephedrine Powder, then the removal in the form of tablets will not be removal as such requiring reversal of credit. If they are removed as Ephedrine tablets after manufacture then these attract Central Excise duty.</description>
      <category>Highlights</category>
      <law>Central Excise</law>
      <pubDate>Sat, 08 Dec 2018 07:46:30 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/highlights?id=43163</guid>
    </item>
  </channel>
</rss>